EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards

Sarah Malecki iD, Anne Loffler, Fangming Liao, Tejasvi Hora, Arnav Agarwal, Sharan Lail, Surain B Roberts, Derek McFadden, Samir Gupta, Fahad Razak, Amol A Verma iD

Journal of Hospital Medicine · 2024

DOI: 10.1002/jhm.13422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hospital Medicine, 2024. Verfasst von Sarah Malecki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Residency Program, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Glucocorticoids, Community-Acquired Infections, Pneumonia, Hospitalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Medical Protective Agency, University of Toronto Department of Medicine, Green Shield Canada Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little is known about the real‐world use of systemic glucocorticoids to treat patients hospitalized with community‐acquired pneumonia (CAP) outside of the intensive care unit (ICU).

Methods

This retrospective cohort study included 11,588 hospitalizations for CAP without chronic pulmonary disease at seven hospitals in Ontario, Canada. We report physician‐level variation in the use of glucocorticoids and trends over time. We investigated the association between glucocorticoid prescriptions and clinical outcomes, using propensity score overlap weighting to account for confounding by indication.

Results

Glucocorticoids were prescribed in 1283 (11.1%) patients, increasing over time from 10.0% in 2010 to 11.9% in 2020 ( p = .008). Physician glucocorticoid prescribing ranged from 2.9% to 34.6% (median 10.0%, inter quartile range [IQR]: 6.7%–14.6%). Patients receiving glucocorticoids tended to be younger (median age 73 vs. 79), have higher Charlson comorbidity scores (score of 2 or more: 42.4% vs. 31.0%), more cancer (26.6% vs. 13.2%), more renal disease (11.5% vs. 6.6%), and less dementia (7.8% vs. 14.8%). Patients treated with glucocorticoids had higher rates of in‐hospital mortality (weighted Risk Difference = 1.72, 95% confidence interval [95% CI]: 0.16–3.3, p = .033). Glucocorticoid use was not associated with ICU admission, hospital length‐of‐stay, or 30‐day readmission.

Conclusion

Glucocorticoids were prescribed in 11.1% of patients hospitalized with CAP outside of ICU and one in four physicians prescribed glucocorticoids in more than 14% of patients. Glucocorticoid use was associated with greater in‐hospital mortality, although these findings are limited by large selection effects. Clinicians should exercise caution in prescribing glucocorticoids for nonsevere CAP, and definitive trials are needed in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsCommunity-Acquired InfectionsPneumoniaHospitalizationHumansMaleRetrospective StudiesFemaleAgedOntarioMiddle AgedAged, 80 and overHospital MortalityIntensive Care UnitsPractice Patterns, Physicians'

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Internal Medicine Residency Program, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
  • The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

ORCID-Profile: Sarah Malecki, Amol A Verma

Förderung

  • Canadian Medical Protective Agency
  • University of Toronto Department of Medicine
  • Green Shield Canada Foundation
  • Canadian Cancer Society
  • Saint Michael's Hospital Association Innovation Fund
  • Natural Sciences and Engineering Research Council of Canada
  • Ontario Health
  • Canadian Frailty Network

Zitieren

APA

Malecki, S., Loffler, A., Liao, F., Hora, T., Agarwal, A., Lail, S., Roberts, S. B., McFadden, D., Gupta, S., Razak, F., & Verma, A. A. (2024). Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.13422

Vancouver

Malecki S, Loffler A, Liao F, Hora T, Agarwal A, Lail S, et al. Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards. Journal of Hospital Medicine. 2024. doi:10.1002/jhm.13422

BibTeX
@article{Malecki2024,
  author = {Malecki, Sarah and Loffler, Anne and Liao, Fangming and Hora, Tejasvi and Agarwal, Arnav and Lail, Sharan and Roberts, Surain B and McFadden, Derek and Gupta, Samir and Razak, Fahad and Verma, Amol A},
  title = {Real‐world use of glucocorticoids and clinical outcomes in adults hospitalized with community‐acquired pneumonia on medical wards},
  journal = {Journal of Hospital Medicine},
  year = {2024},
  doi = {10.1002/jhm.13422}
}
Kostenlos starten →